I agree that this may be an important paper. I am just not optimistic that there will be any way of fixing this. The track record on treatments for other neurological diseases is not so good.
MECFS research should be able to leverage the huge funding for MS, especially, for symptom treatments. MS and MECFS both have fatigue and cognitive dysfunction as major symptoms. If a treatment works for these symptoms in MS, then likely it will work for these same symptoms in MECFS.
So the big European MS meeting just finished a couple of days ago. The scientific program book is 131 pages long for a three day meeting!!
https://www.professionalabstracts.com/ectrims2019/programme-ectrims2019.pdf
Why is there so much more MS research than MECFS research? Are there really...
In his recent talk at Stanford, Dr. Fluge mentioned (I think) that the cyclophosphamide open trial will need to be followed up with a RCT trial. @Jonathan Edwards mentioned previously that it is not possible to blind a cyclophosphamide trial because it induces severe nausea. So what to do...
Here is a CNN article
https://www-m.cnn.com/2019/09/10/europe/norway-dog-disease-intl-hnk-scli/index.html?r=https%3A%2F%2Fwww.cnn.com%2Fsearch%3Fq%3DDogs%2BNorway
https://www.nytimes.com/2019/09/10/world/europe/norway-dog-deaths.html?action=click&module=Latest&pgtype=Homepage
Lot of stuff going on in Norway....why am I sure that this story will garner far more media coverage than all the MECFS issues in Norway?
anybody on here attending in person?
Maybe someone can find out the status of the Fluge cyclophosphamide study publication? Long way to submitting/ready to submit/in review?
Or maybe he might mention something about the study during his talk other than that the results are interesting? Of...
Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot study
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0218075
Popular article...
https://n.neurology.org/content/93/8/325
Dalfampridine improves slowed processing speed in MS
Picking up the pace
Accompanying editorial in Neurology to above posted article
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.